All In Biotech

Drug Trial Radar · NCT06471218

Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

Evaluation of the Efficacy and Safety of Multiple Subcutaneous Injections of SHR-1918 in Patients With Hyperlipidemia in Poor Control: a Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trials

Last checked: Nov 19, 2026Latest source record: Feb 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

44

Actual

Start

Jul 2, 2024

Primary completion

May 16, 2025

Study completion May 16, 2025

Sponsor

Sponsor type
Industry
First posted
Jun 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of the efficacy and safety of multiple subcutaneous injections of SHR-1918 in patients with hyperlipidemia in poor control: a multicenter, randomized, double-blind, placebo-controlled phase II clinical trials

Conditions

  • Hyperlipidemia

Interventions

  • SHR-1918; SHR-1918 PlaceboDrug

    SHR-1918/SHR-1918 Placebo,two administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent change in calculated LDL-C from baseline to week 24Time frame: from baseline to week 24

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Meizhou People's Hospital

    Meizhou, Guangdong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.